439 results
Page 2 of 22
8-K
EX-4.2
2sqy2bk
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-1.1
g6mv8d
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-4.1
0yscsg9tc s5w7o15el9
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
zbsh2 v4d4jvg
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
cofrn
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
4xzk7 b7o00hjzj
29 Sep 23
Prospectus supplement
4:56pm
8-K
EX-10.1
ldjiruolbb6tmtn
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-4.1
9mswdg7s5y7z3i
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
lh66 7ekk
25 Sep 23
Prospectus supplement for primary offering
6:02am
8-K
EX-99.2
bsl9iw64bs qfy
20 Sep 23
Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide
7:00am
UPLOAD
mw1a8xb3y 3rs2kbs6w0
20 Sep 23
Letter from SEC
12:00am
8-K
EX-4.2
kwhpotdgjgs8
19 May 23
Entry into a Material Definitive Agreement
5:00pm